Skip to main content

AS-8112









AS-8112


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search








































AS-8112

AS-8112 structure.png
Names

IUPAC name
5-bromo-N-[(6R)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-4-(methylamino)benzamide

Identifiers

3D model (JSmol)



  • Interactive image

  • Interactive image



ChemSpider


  • 9168209 ☑Y



PubChem CID


  • 10993014





Properties

Chemical formula

C17H27BrN4O2

Molar mass
399.325 g/mol

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).


☑Y verify (what is ☑Y☒N ?)

Infobox references



AS-8112 is a synthetic compound that acts as a selective antagonist at the dopamine receptor subtypes D2 and D3, and the serotonin receptor 5-HT3.[1] It has potent antiemetic effects in animal studies and has been investigated for potential medical use.[2][3]



References[edit]





  1. ^ Yoshikawa T, Yoshida N, Oka M (May 2001). "The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist". British Journal of Pharmacology. 133 (2): 253–60. doi:10.1038/sj.bjp.0704078. PMC 1572785. PMID 11350861..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ Yoshikawa T, Yoshida N, Oka M (November 2001). "Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets". European Journal of Pharmacology. 431 (3): 361–4. doi:10.1016/S0014-2999(01)01459-5. PMID 11730730.


  3. ^ Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S (February 2003). "Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity". Journal of Medicinal Chemistry. 46 (5): 702–15. doi:10.1021/jm020270n. PMID 12593651.















Retrieved from "https://en.wikipedia.org/w/index.php?title=AS-8112&oldid=721088482"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.732","walltime":"0.923","ppvisitednodes":{"value":4225,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":341407,"limit":2097152},"templateargumentsize":{"value":13053,"limit":2097152},"expansiondepth":{"value":20,"limit":40},"expensivefunctioncount":{"value":3,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":9769,"limit":5000000},"entityaccesscount":{"value":3,"limit":400},"timingprofile":["100.00% 647.528 1 -total"," 69.61% 450.726 1 Template:Chembox"," 46.27% 299.630 1 Template:Chembox_Identifiers"," 30.07% 194.682 3 Template:Chembox_headerbar"," 29.58% 191.540 9 Template:Trim"," 17.30% 112.003 20 Template:Navbox"," 16.77% 108.569 5 Template:Main_other"," 16.73% 108.340 1 Template:Reflist"," 14.67% 94.970 3 Template:Cite_journal"," 14.52% 94.052 1 Template:Chembox_parametercheck"]},"scribunto":{"limitreport-timeusage":{"value":"0.263","limit":"10.000"},"limitreport-memusage":{"value":5356226,"limit":52428800}},"cachereport":{"origin":"mw1331","timestamp":"20181215044808","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":91,"wgHostname":"mw1254"});});

Popular posts from this blog

Coverage of Google Street View

Full-time equivalent

Surfing